Search Results 81-90 of 18248 for Hepatitis C

  1. Ribavirin (oral route) - Mayo Clinic

    For hepatitis C virus infection, in combination with interferon alfa-2b: For oral dosage form (capsules):. Adults—Dose is based on body weight and must be ...

  2. A Study to Compare the Effectiveness and Safety of ABT-493/ABT-530 to Sofosbuvir Given Together with Declatasvir in Adults with a Chronic Hepatitis C Virus Infection - Mayo Clinic

    A Study to Compare the Effectiveness and Safety of ABT-493/ABT-530 to Sofosbuvir Given Together with Declatasvir in Adults with a Chronic Hepatitis C Virus ...

  3. A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-Administration of ABT-493 and ABT-530 With and Without RBV in Subjects With Chronic Hepatitis C Virus (HCV) Genotypes 2, 3, 4, 5 or 6 Infection - Mayo Clinic

    ... Hepatitis C Virus (HCV) Genotypes 2, 3, 4, 5 or 6 Infection. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo ...

  4. A Study Comparing Measurements of Response to Antiviral Treatments for Liver Transplant Patients that have Recurrent Hepatitis C - Mayo Clinic

    ... liver transplant, are immune suppressed with Neoral or tacrolimus, and have a recurring infection with the Hepatitis C virus. Participation eligibility.

  5. A Multicenter Treatment Protocol of Daclatasvir (BMS-790052) in Combination With Sofosbuvir for the Treatment of Post-Liver Transplant Subjects With Chronic Hepatitis C - Mayo Clinic

    Patients chronically infected with Hepatitis C · Subjects who received a liver transplant, have chronic hepatitis C virus (HCV) recurrence and advanced fibrosis ...

  6. Liver problems - Symptoms and causes - Mayo Clinic

    Hepatitis C. Immune system condition. Diseases in which the immune system attacks certain parts of the body are called autoimmune diseases. Autoimmune liver ...

  7. Sofosbuvir, velpatasvir, and voxilaprevir (oral route) - Mayo Clinic

    Description. Sofosbuvir, velpatasvir, and voxilaprevir combination is used to treat chronic hepatitis C infection in adults (with or without cirrhosis) who ...

  8. The epigenome as a link between the environment and human disease - Research - Mayo Clinic Research

    ... liver disease progression and hepatocellular carcinoma. The Epigenetic Etiology of Human Disease Laboratory studies the impact of hepatitis C virus infection on ...

  9. Mayo Clinic Studies Identify Risk Factors in Rising Trend of Liver Cancer

    ... hepatitis C infection. "The liver scarring from hepatitis C can take 20 to 30 years to develop into cancer," Dr. Kim says. "We're now seeing cancer patients ...

  10. Simeprevir (oral route) - Mayo Clinic

    ... hepatitis C infection. These medicines are used in patients with liver disease (including cirrhosis) who have not been treated before or who have received ...